-
公开(公告)号:US20090137579A1
公开(公告)日:2009-05-28
申请号:US12288596
申请日:2008-10-22
IPC分类号: A61K31/5377 , C07D413/14
CPC分类号: C07D471/04
摘要: The present invention is directed to the compound of formula (II), or a solvate thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (II), including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of a compound of formula (II), or crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.
摘要翻译: 本发明涉及式(II)化合物或其溶剂化物或其结晶形式; 涉及药物组合物,其包含药学上有效量的式(II)化合物,包括其结晶形式和药学上可接受的载体; 以及使用式(II)化合物或其结晶形式用于治疗患有或受其抑制IKK-2能够改善的病理状况的患者及其相关方法。
-
公开(公告)号:US20090131422A1
公开(公告)日:2009-05-21
申请号:US12288595
申请日:2008-10-22
IPC分类号: A61K31/5377 , C07D413/14 , A61P29/00
CPC分类号: C07D471/04
摘要: The present invention is directed to the Tartrate, Mono-Hydrochloride, Malonate and p-Toluenesulfonate Salts of the compound of formula (I), or solvates thereof, or crystalline forms thereof; to a pharmaceutical composition comprising a pharmaceutically effective amount of the Salts, including crystalline forms thereof, and a pharmaceutically acceptable carrier; and to the use of the Salts, including crystalline forms thereof, for treating a patient suffering from, or subject to, a pathological condition capable of being ameliorated by inhibiting IKK-2, and methods related thereto.
摘要翻译: 本发明涉及式(I)化合物或其溶剂合物或其结晶形式的酒石酸盐,单盐酸盐,丙二酸盐和对甲苯磺酸盐盐; 涉及包含药学有效量的盐,包括其结晶形式的药物组合物和药学上可接受的载体; 以及使用包括其结晶形式的盐,用于治疗患有或受其抑制IKK-2能够改善的病理状况的患者及其相关方法。
-
3.
公开(公告)号:US20090181966A1
公开(公告)日:2009-07-16
申请号:US12321910
申请日:2009-01-27
申请人: Shomir Ghosh , Amy M. Elder , Kenneth G. Carson , Kevin T. Sprott , Sean J. Harrison , Frederick A. Hicks , Christelle C. Renou , Dominic Reynolds
发明人: Shomir Ghosh , Amy M. Elder , Kenneth G. Carson , Kevin T. Sprott , Sean J. Harrison , Frederick A. Hicks , Christelle C. Renou , Dominic Reynolds
IPC分类号: A61K31/47 , C07D215/42 , A61K31/5377 , A61P37/08 , C07D413/06
CPC分类号: C07D471/04 , A61K31/4353 , A61K31/47 , C07D215/42 , C07D215/44 , C07D401/06 , C07D401/10 , C07D401/12 , C07D405/06 , C07D409/06 , C07D413/06 , C07D413/10 , C07D417/06 , C07D491/04 , C07D495/04
摘要: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
摘要翻译: 本文公开的是由结构式(I)和(IA)表示的化合物:还公开了这样的化合物用于抑制称为Th2上表达的化学引诱物受体同源分子的G-蛋白偶联受体,或简称为“CRTH2”,用于 治疗炎症性疾病。 结构式(I)和(I-A)中的变量在本文中定义。
-
公开(公告)号:US07504508B2
公开(公告)日:2009-03-17
申请号:US11101208
申请日:2005-04-07
申请人: Shomir Ghosh , Amy M. Elder , Kenneth G. Carson , Kevin T. Sprott , Sean J. Harrison , Frederick A. Hicks , Christelle C. Renou , Dominic Reynolds
发明人: Shomir Ghosh , Amy M. Elder , Kenneth G. Carson , Kevin T. Sprott , Sean J. Harrison , Frederick A. Hicks , Christelle C. Renou , Dominic Reynolds
IPC分类号: C07D215/38
CPC分类号: C07D405/06 , C07D215/42 , C07D215/44 , C07D401/04 , C07D401/06 , C07D401/12 , C07D413/06 , C07D413/10 , C07D417/06
摘要: Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simply “CRTH2” for the treatment of inflammatory disorders. The variables in Structural Formula (I) and (I-A) are defined herein.
-
-
-